Gary W. Pace, Director at Pacira Pharmaceuticals, Inc. (PCRX), bought 4,500 shares at $46.18 ($208K) on 2018-11-19, disclosed to the SEC on 2018-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CRDF | BUY | 2025-07-31 | $711K | — | Filing → |
| CRDF | BUY | 2024-12-12 | $940K | — | Filing → |
| PCRX | SELL | 2024-03-08 | $4.5M | — | Filing → |